🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementNausea incidence by dose tier — my results so far Page 8

Nausea incidence by dose tier — my results so far

MikeFit_NJ Mon, Jul 22, 2024 at 7:15 AM 52 replies 2,374 viewsPage 8 of 11
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Sep 29, 2024 at 7:31 AM#36

Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Sep 29, 2024 at 1:31 PM
15 13FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 12 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Oct 3, 2024 at 3:24 AM#37
NurseAsh_DET said:
The mechanism and the magnitude are separate questions.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

16 14Dr.PathRoch, mona_PHX, andrew_nyc and 13 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Oct 6, 2024 at 11:15 PM#38
NurseAsh_DET said:
The mechanism and the magnitude are separate questions.

There is a second half to this that has not been said yet. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

17 15AmyNC_wife, SkepticalSean, Dr.CardioMD and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Oct 10, 2024 at 7:04 PM#39

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

18 16ben_calgary, patPC_UT, Dr.DermMIA and 15 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Oct 14, 2024 at 2:50 PM#40

Following on from NurseAsh_DET — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

40 13RickReta_CO, PharmHunterJen, TomTeleRx and 37 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register